Meeting the future at the Munich conference ESCMID-Global 2026
By
Johannes R. Bogner
June 2, 2026
Clinical Scorecard: Exploring Future Innovations at the ESCMID-Global Conference 2026 in Munich
At a Glance
Category Detail
Condition Infectious Diseases Key Mechanisms Artificial Intelligence in early detection and management of sepsis; Phage therapy; New antibacterial mechanisms against multi-resistant pathogens. Target Population Participants in microbiology and infectious diseases research and clinical practice. Care Setting Scientific conference setting.
Key Highlights
17,256 participants registered, with optimal organization and flow of events. Keynote on rheumatic heart disease by Liesl Zühlke addressing global burden and prevention. Nicholas Day discussed neglected rickettsial infections and the need for greater awareness. Advances in metagenomic next sequencing techniques to improve diagnostic sensitivity. Overview of AI applications in sepsis management presented by Sylvan Meylan. Guideline-Based Recommendations
Diagnosis
Increased awareness and investment in neglected infections like rickettsioses. Management
Utilization of AI for improved management of sepsis and septic shock. Monitoring & Follow-up
Ongoing evaluation of new diagnostic techniques and their implementation. Risks
Challenges in interpretation and cost of metagenomic sequencing may hinder adoption. Patient & Prescribing Data
Children and young adults in low- and middle-income countries affected by rheumatic heart disease.
Need for coordinated global action to reduce morbidity and mortality from RHD.
Clinical Best Practices
Focus on prevention and early detection of rheumatic heart disease. Enhance diagnostic capabilities for neglected infections. Related Resources & Content
